• Duphat
  • infinia camp
  • Emirates Digestive Diseases
MedEdge MEA MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Reading: Diabetes is a Global Concern with 10% of he population Affected | Dr. Mohamed Al-Sayed Al-Shabrawey
Share
Notification
  • Duphat
  • infinia camp
  • Emirates Digestive Diseases
MedEdge MEA
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Have an existing account? Sign In
MedEdge MEA > Video > Diabetes is a Global Concern with 10% of he population Affected | Dr. Mohamed Al-Sayed Al-Shabrawey
Video

Diabetes is a Global Concern with 10% of he population Affected | Dr. Mohamed Al-Sayed Al-Shabrawey

ME Desk
ME Desk
Published: March 22, 2025
Share
1 Min Read
SHARE
Dr. Mohamed Al-Sayed Al-Shabrawey discusses his ongoing research on new therapeutic targets for diabetic retinopathy at Duphat 2025. With diabetes affecting millions globally, and a significant percentage developing diabetic retinopathy, there is an urgent need for innovative solutions. Dr. Al Shabrawey talks about promising therapies like bone morphogenic protein and the rapid growth of artificial intelligence in ophthalmology, shaping the future of eye care.

#MedEdgeMEA #DiabeticRetinopathy #Ophthalmology #AIInHealthcare #ResearchInnovation #Duphat2025

Also watch : Pediatric Hematology & Cancer Care | Dr. muhammad faisal khanani | BMT

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article Pediatric Hematology & Cancer Care | Dr. muhammad faisal khanani | BMT
Next Article AI in Critical Care: Dr. Lama’s Insights on Sepsis, Ethics, and the Future of Healthcare | SCCM

Recent Posts

  • NIH research clears way for study of experimental treatment for opioid use disorder
  • ASCO awards Eduardo Vilar-Sanchez, M.D., Ph.D., for cancer prevention research | ASCO 2026
  • King Faisal Hospital Ranks 12th Globally in Brand Finance 2026
  • Seventy-ninth World Health Assembly honours global champions advancing primary health care
  • DRC and WHO Issue Joint Statement on Bundibugyo Ebola Outbreak
  • duphat
  • MedEdge-Infinia
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Diabetes is a Global Concern with 10% of he population Affected | Dr. Mohamed Al-Sayed Al-Shabrawey
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: Diabetes is a Global Concern with 10% of he population Affected | Dr. Mohamed Al-Sayed Al-Shabrawey
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?